Nexien BioPharma (NXEN, $0.01) was a top loser over the last three months, falling -2 to $0.01 per share. A.I.dvisor analyzed 234 stocks in the Pharmaceuticals: Other Industry for the 3-month period ending November 14, 2024, and found that of them (3) exhibited an Uptrend while of them (6) demonstrated a Downtrend.